Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Ganglioglioma
100%
Glioblastoma
68%
Surgery
64%
Meningioma
64%
DNA Methylation
48%
Magnetic Resonance Imaging
42%
Neoplasm
32%
Tumor Progression
32%
Elderly Patient
32%
Tumor Microenvironment
32%
Temozolomide
32%
Brain Ventricle Tumor
32%
Macrophage
32%
Pediatrics
32%
Pilocytic Astrocytoma
32%
Subdural Hematoma
32%
Craniotomy
32%
Intraoperative MRI
32%
3D Imaging
32%
Tumor Cell
25%
In Vitro
18%
Sequela
16%
Aphasia
16%
Cerebellum Tumor
16%
Histone H3
16%
Tumor of Central Nervous System
16%
Posaconazole
16%
Head Imaging
16%
Cerebellum
16%
Formaldehyde
16%
Frontal Lobe
16%
Pediatric Brain Tumor
16%
Chemoradiotherapy
16%
Genetic Analysis
16%
Social Participation
12%
Diffusion MRI
11%
Diffusion Tensor Imaging
10%
Embolization
10%
Middle Temporal Gyrus
10%
Vascularity
10%
Bleeding
10%
Surgical Planning
10%
Prognostic Factor
9%
Macrophage Migration
9%
In Silico
9%
Methylation
8%
Disease
6%
Clinician
6%
Keyphrases
Cerebellar Abscess
32%
Organized Chronic Subdural Hematoma
32%
Ad-SGE-REIC
32%
Combination Antifungal Therapy
32%
Cladophialophora Bantiana
32%
Tumor Invasion
32%
GBM Cells
32%
Diffuse High-grade Gliomas
32%
Glioma Surgery
32%
Tectal Glioma
32%
Tumor Angiogenesis
32%
Glioma Progression
32%
Bevacizumab
32%
Awake Craniotomy
32%
Awake Surgery
32%
3D Imaging
32%
Trigonal
32%
Meningioma
32%
Imaging Analysis
32%
Cerebellar Mass
16%
ITS-sequencing
16%
Rare Fungal Infections
16%
Head Imaging
16%
Phaeohyphomycosis
16%
Posaconazole
16%
GBM Stem-like Cells
16%
Hypothalamic Damage
16%
Language Cortex
16%
Occupying Lesions
16%
Language Area
16%
Temozolomide Chemotherapy
10%
Molecular Assessment
10%
Gross Total Resection
10%
Surgical Difficulty
10%
3D Imaging System
10%
Preoperative Embolization
10%
Neuroanatomical
10%
Optic Radiation
10%
Blood Loss
10%
Diffusion Tensor Imaging
10%
Planning Outcomes
10%
Tumor Vascularization
10%
Older Women
10%
Middle Temporal Gyrus
10%
Precise Mapping
10%
Deep Location
10%
Improved Outcomes
10%
Surgical Planning
10%
Overall Survival
8%
Combination Therapy
8%
